The contribution of clinical and pathological predisposing factors to severe gastro-duodenal lesions in patients with long-term low-dose aspirin and proton pump inhibitor therapy.
Sign Up to like & getrecommendations! Published in 2017 at "European journal of internal medicine"
DOI: 10.1016/j.ejim.2017.05.017
Abstract: BACKGROUND Preventive strategies developed to avoid the complications of antiplatelet therapies recommend the evaluation of risk factors for gastrointestinal events and indicated gastroprotective strategies. AIM We aimed to assess the impact of predisposing factors -… read more here.
Keywords: low dose; duodenal lesions; gastro duodenal; lesions patients ... See more keywords
Effect of Novel Gastro-Duodenal Flow Restrictor on Relative Weight Loss and Glucose Levels in a Porcine Model: A Pilot Randomized Study
Sign Up to like & getrecommendations! Published in 2022 at "Nutrients"
DOI: 10.3390/nu14132563
Abstract: Endoscopic bariatric and metabolic therapies are promising for obesity. We developed a novel gastro-duodenal flow restrictor (G-DFR) device for relative weight loss and lowering of glucose level and evaluated its safety and efficacy in a… read more here.
Keywords: relative weight; group; efficacy; gastro duodenal ... See more keywords
Major gastrointestinal bleeding and antithrombotics: Characteristics and management
Sign Up to like & getrecommendations! Published in 2020 at "World Journal of Gastroenterology"
DOI: 10.3748/wjg.v26.i36.5463
Abstract: BACKGROUND There are few reports on major gastrointestinal (GI) bleeding among patients receiving an antithrombotic. AIM To describe clinical characteristics, bleeding locations, management and in-hospital mortality related to these events. METHODS Over a three-year period,… read more here.
Keywords: gastrointestinal bleeding; bleeding; management; gastro duodenal ... See more keywords